Search filters

List of works by Cathia Soulié

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

scientific article published on 17 December 2014

Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

scientific article published on 25 October 2014

Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma

scientific article published on 2 May 2017

Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments

scientific article published on February 2014

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

scientific article published in August 2012

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations

scientific article published on 25 November 2011

Effect of antiretroviral drugs on the quality of semen

scientific article published in August 2011

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

scientific article

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy

scientific article

Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists

scientific article

Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir

scientific article

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B.

scientific article

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

scientific article published on 30 September 2014

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes

scientific article

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis

article

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

scientific article published on 11 June 2015

HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART

article

HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs

scientific article published on 11 June 2012

Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia

scientific article published on 26 January 2011

Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease

scientific article published in September 2008

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

scientific article published on 25 June 2012

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years

article

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

scientific article published on 16 February 2014

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro

scientific article published on 28 January 2008

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

scientific article

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibit

scientific article published in July 2009

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

scientific article published on 20 January 2015

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study: Figure 1

scientific article published on 26 April 2015

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

scientific article published on 31 January 2011

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

scientific article

Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients

scientific article published in October 2008

Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients

scientific article published on 16 February 2009

Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)

scientific article

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

scientific article published on 17 July 2015

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

scientific article

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

scientific article published on April 2015

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

scientific article

Virological failure of patients on maraviroc-based antiretroviral therapy

scientific article published on 19 February 2015

Paulina is supported by:

About Paulina

Help